Common use of References Clause in Contracts

References. ECHA, European Chemicals Agency. 2012 Guidance on information requirements and chemical safety assessment. Chapter R.11: PBT Assessment and Chapter R.16: Environmental Exposure Estimation. Cymbalta Package Insert. xxxx://xx.xxxxx.xxx/xx/xxxxxxxx-xx.xxx Cymbalta (32%) Capsules Safety Data Sheet. Revision 09/24/2015. xxxx://xxx.xxxxx.xxx/xxxx/Xxxxxxxx.xxx Xxxx J, Xxxxxxxx RH, Xxx L, Xxxxxxxxx-Xxxxxx X. 2011. Results from the Swedish National Screening Programme 2010. Subreport 3. Pharmaceuticals. Swedish Environmental Research Institute. IVL Report B2014. 56 pp. Xxxx J, Xxxxxxx RH, Xxxx J, Xxxxxx J, Xxx L, Xxxxxxxxx-Xxxxxx X. 2015. Screening 2014 Analysis of pharmaceuticals and hormones in samples from WWTPs and receiving waters. 2015. IVL Swedish Environmental Research Institute. Number C135. 51 pp. Xxxxxxx M, Xxxxx A, Xxxxxx R, Xxxx J, Xxxxxxxx M, la Cour Xxxxxx J, Xxxxxxxx HR. 2011. Determination of sorption of seventy-five pharmaceuticals in sewage sludge. Wat Res 45:4470-4482. Xxxxx XX, Xxxxxxxxx TA, Xxxx TJ, Xxx F, Xxxxxxx M, Kuan H-Y, Xxxxxxx MP. 2003. Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. Drug Disp Metab

References. ECHA, European Chemicals Agency. 2012 Guidance on information requirements and chemical safety assessment. Chapter R.11: PBT Assessment and Chapter R.16: Environmental Exposure Estimation. Cymbalta Package Insert. xxxx://xx.xxxxx.xxx/xx/xxxxxxxx-xx.xxx Cymbalta (32%) Capsules Safety Data Sheet. Revision 09/24/2015. xxxx://xxx.xxxxx.xxx/xxxx/Xxxxxxxx.xxx Xxxx J, Xxxxxxxx RH, Xxx L, Xxxxxxxxx-Xxxxxx X. 2011. Results from the Swedish National Screening Programme 2010. Subreport 3. Pharmaceuticals. Swedish Environmental Research Institute. IVL Report B2014. 56 pp. Xxxx J, Xxxxxxx RH, Xxxx J, Xxxxxx J, Xxx L, Xxxxxxxxx-Xxxxxx X. 2015. Screening 2014 Analysis of pharmaceuticals and hormones in samples from WWTPs and receiving waters. 2015. IVL Swedish Environmental Research Institute. Number C135. 51 pp. Xxxxxxx M, Xxxxx A, Xxxxxx R, Xxxx J, Xxxxxxxx M, la Cour Xxxxxx J, Xxxxxxxx HR. 2011. Determination of sorption of seventy-five pharmaceuticals in sewage sludge. Wat Res 45:4470-4482. Xxxxx XX, Xxxxxxxxx TA, Xxxx TJ, Xxx F, Xxxxxxx M, Kuan Xxxx H-Y, Xxxxxxx MP. 2003. Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. Drug Disp Metab

References. Altamura A, Xxxx A, and Percudani M. 1994. Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet 26(3): 201-214. Xxxxxxx VKH, Tyrefors NL, Xxxxxxxxx IM, Xxxxxxxxxx CE. 2012. Trace analysis of fluoxetine and its metabolite norfluoxetine. Part II: Enantioselective quantification and studies of matrix effects in raw and treated wastewater by solid phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatog A 1227:105-114. Xxxxxxxxx R, Xxxxxxxxx L, Xxxxx N, Xxxxx R. 1988. Clinical pharmacology and pharmacokinetics of fluoxetine: A Review. Br J Psychiatry. 153 (suppl. 3) 47-50. Xxxxxx BW, Xxxxxx XX, Xxxxxxx JK, Xxxxxx JJ, Xxxxxxxxx EA, Xxxxx CM, Xxxxxxxx M, La Point TW, Xxxxxxx DB. 2003. Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere 52:135-142. Xxxxxx XX, Xxxxx SJ, Xxxxxx MS, Xxxxxxxx XX. 2008. Spatial and temporal analysis of pharmaceutical concentrations in the upper Tennessee River basin. Chemosphere 73:1178-1187. ECHA, European Chemicals Agency. 2012 Guidance on information requirements and chemical safety assessment. Chapter R.11: PBT Assessment and Chapter R.16: Environmental Exposure Estimation. Cymbalta Package Insert. xxxx://xx.xxxxx.xxx/xx/xxxxxxxx-xx.xxx Cymbalta (32%) Capsules Safety Data Sheet. Revision 09/24/2015. xxxx://xxx.xxxxx.xxx/xxxx/Xxxxxxxx.xxx Xxxx J, Xxxxxxxx RH, Xxx L, Xxxxxxxxx-Xxxxxx X. 2011. Results from the Swedish National Screening Programme 2010. Subreport 3. Pharmaceuticals. Swedish Environmental Research Institute. IVL Report B2014. 56 pp. Xxxx J, Xxxxxxx RH, Xxxx J, Xxxxxx J, Xxx L, Xxxxxxxxx-Xxxxxx X. 2015. Screening 2014 Analysis of pharmaceuticals and hormones in samples from WWTPs and receiving waters. 2015. IVL Swedish Environmental Research Institute. Number C135. 51 pp. Xxxxxxx M, Xxxxx ACM, Xxxxxx R, Xxxx J, Xxxxxxxx M, la Cour Xxxxxx JBW, Xxxxxxx DB. 2004. Reproductive assessment of Japanese medaka (Oryzias latipes) following a four-week fluoxetine (SSRI) exposure. Arch Environ Contam Toxicol 46:511-517. Xxxx M, Xxxxxxxx HRM, Xxxxxxx D. 2009. 2011Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal Chem 81:898-912. Henry TB, Black MC. 2008. Acute and chronic toxicity of fluoxetine (selective serotonin reuptake inhibitor) in western mosquitofish. Arch Environ Contam Toxicol 54:325-330. Xxxxx TB, Kwon J-W, Xxxxxxxx KL, Black MC. 2004. Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ Toxicol Chem 23:2229-2233. Xxxxxx DW, Xxxxxxx ET, Xxxxx MT, Xxxxxxx EM, Zaugg SD, Xxxxxx LB, Buxton HT 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. stream, 1999-2000: A national reconnaissance. Environ Sci Technol 36:1202-1211 Kwon J-W, Armbrust KL. 2006. Laboratory persistence and fate of fluoxetine in aquatic environments. Environ Toxicol Chem 25:2561-2568. Lajeunesse A, Xxxxxx C, Sauve S. 2008. Determination of sorption of seventybasic antidepressants and their N-five pharmaceuticals desmethyl metabolites in raw sewage sludgeand wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Wat Res 45:4470Anal Chem 80 (14): 5325-4482. Xxxxx XX5333 Xxxxxxxxx L, Xxxxxxxxx TAR, Xxxxx R, Xxxxx N, Xxxx TJG, Xxxxxxx G. 1985. Fluoxetine: Clinical pharmacology and physiologic disposition. J Clin Psychiatry 46:14-19. Xxxxxx A, Xxxxx X, Xxx FXxxx J, Xxxxxxx MXxx Xxx Xxxxx X. 2009. Inhibition of egg production in zebrafish by fluoxetine and municipal effluents: A mechanistic evaluation. Aq Toxicol 95:320-329. Metcalfe CD, Kuan HMiao X-S, Xxxxxx BG, Struger J. 2003. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower great lakes, Canada. Env Toxicol Chem 22:2881-2889 Xxxxxxxx Y, Xxxxxxx MP. 2003. MetabolismXxxxxxxx H, excretionXxxxxxxx J, and pharmacokinetics of duloxetine in healthy human subjects. Drug Disp MetabXxxxx T, Xxxxx N, Xxxxxxxxxx